Breaking News

LAWSUITS FILED AGAINST NXTC, GOCO and GLNG

NEW YORK, NY / ACCESSWIRE / November 5, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below.

Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Nextcure, Inc. (NASDAQ:NXTC)

CONTACT JAKUBOWITZ ABOUT NXTC :

https://claimyourloss.com/securities/nextcure-inc-loss-submission-form/?id=10743&from=1

The Nextcure lawsuit was filed on behalf of investors who purchased Nextcure, Inc. (NASDAQ: NXTC) securities: (1) between November 5, 2019 and July 14, 2020, inclusive; and/or (2) pursuant or traceable to the company’s secondary public offering declared effective on November 14, 2019.

Lead Plaintiff Deadline : November 20, 2020

Throughout the class period defendants’ statements were materially misleading because the data Defendants possessed on its principle product candidate, NC318, showed a lack of efficacy and objective responses. Had the truth been revealed, the market would have seen that NC318 was not, in fact, effective in treating most tumor types, that the NC318 application was proving to be limited (if even useful at all), and, as a result, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster…

ACCESSWIRE

Read full article



Source link